Neoadjuvant Chemotherapy with Docetaxel and Cisplatin in Patients with High-Risk Resectable Bladder Carcinoma: Long Term Results

Aristotelis Bamias; C. Deliveliotis; A. Karayiannis; Ioannis Varkarakis; Iannis M. Zervas; D Pantazopoulos; Dimitra Gika; Meletios A Dimopoulos

doi:10.1016/j.eururo.2004.04.024

Related publications

Article2018

Neoadjuvant chemotherapy (NAC) with dose-dense gemcitabine/cisplatin (DDGC) in localized muscle-invasive bladder cancer (MIBC).

G. P. Tsironis, Roubini Zakopoulou, Konstantinos Koutsoukos, Kimon Tzanis, John Varkarakis, Athanasios Papatsoris, Konstantinos Stravodimos, E. Kostouros, Charalampos Fragkoulis, Theodosia Choreftaki, Dimitrios Filippiadis, Sofia Fontara, Athanasios Dellis, Sparti Ntai, Anna Zygogianni, Konstantinos Ntoumas, Constantinos Constantinides, Penelope Korkolopoulou, Meletios A Dimopoulos, Aristotelis Bamias

Article2005

Neoadjuvant chemotherapy in invasive bladder cancer

Aristotle Bamias, Meletios A Dimopoulos

Article2001

Randomized trials of adjuvant and neoadjuvant chemotherapy in bladder cancer.

Meletios A Dimopoulos, Eleni Galani

Article1997

Docetaxel and cisplatin (DC) combination chemotherapy for metastatic urothelial cancer

Meletios A Dimopoulos, G. Louras, D Pantazopoulos, C. Deliveliotis, C. Constantinidis, C. Papadimitriou, Constantinos Papadimitris, Zacharias Kyriakakis, Dionysios Mitropoulos, V. Georgoulias

Article2022

<scp>CINSARC</scp> in high‐risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the <scp>ISG‐STS</scp> 1001 study

Anna Maria Frezza, Silvia Stacchiotti, Frédéric Chibon, Jean‐Michelle Coindre, Antoîne Italiano, Cleofe Romagnosa, Sílvia Bagué, Angelo Paolo Dei Tos, Luca Braglia, Emanuela Palmerini, Vittorio Quagliuolo, Javier Martín‐Broto, Antonio López–Pousa, Giovanni Grignani, Antonella Brunello, Jean Yves Blay, Robert Díaz Beveridge, Iwona Ługowska, Tom Lesluyes, Roberta Maestro, Domenico Franco Merlo, Paolo G. Casali,